- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06771869
Comparing Sodium to Fluid Balance in Predicting Respiratory Dysfunction in Critically Ill Septic Patients
Sodium Balance Rather Than Fluid Balance as a Predictor of Respiratory Dysfunction in Critically Ill Septic Patients on Mechanical Ventilation; a Prospective Observational Study
Study Overview
Detailed Description
This prospective observational cohort study assesses the effect of cumulative positive sodium balance on respiratory function in critically ill septic mechanically ventilated patients Patients admitted to the ICU for 6 months with Age more than 13 yrs. and less than 70 years, an APACHE II score of more than 12 is calculated on admission, and a SOFA score of more than 2 is calculated on admission. Septic patients who manifested by 2 or more of the following conditions: Temperature >38oC or <36oC, Heart rate >90 beats/min, Respiratory rate >20 breaths/min or PaCO2 <32mmHg, White blood cell count >12000/mm3, <4000/mm3 or >10% immature (band) forms, Mechanically ventilated patients for less than 48 hours and who were anticipated to be on MV for at least another 48 hours, Serum sodium concentration between 130 mmol/L and 150 mmol/L will be included in the study.
Data will be collected on the first three days after recruitment, with Day 1 being the day of enrollment. These include the Daily PaO2/FiO2 ratio, Daily urine output, and fluid balance. Routine laboratory investigations include Liver function tests, including ALT, AST, serum bilirubin, and serum albumin. Kidney function tests including serum creatinine and urea level. Complete blood count (CBC). Arterial blood gases. Serum lactate level.
Sodium and fluid intakes will be calculated and recorded for all solutions as the type and volume administered over each 24-hour study day for 3 days.
The primary outcome will be oxygenation (PaO2/FiO2 ratio) and length of MV stay while the Secondary outcomes include Length of ICU and hospital stay, ICU and hospital mortality, and SOFA scores at diagnosis of sepsis, Presence of shock (defined as requirement for vasopressor infusion at any dose for more than 6 hours).
Labs specific for our study (on ICU admission and if needed):
- Procalcitonin (PCTQ).
- CRP.
- Serum electrolytes: Na, K, Ca
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt, 69711
- Ain Shams University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- APACHE II score of more than 12 calculated on admission.
- SOFA score of more than 2 calculated on admission.
Septic patients who manifested by 2 or more of the following conditions:
- Temperature >38oC or <36oC
- Heart rate >90 beats/min
- Respiratory rate >20 breaths/min or PaCO2 <32mmHg.
- White blood cell count >12000/mm3, <4000/mm3 or >10% immature (band) forms.
- Mechanically ventilated patients for less than 48 hours and who were anticipated to be on MV for at least another 48 hours.
- Serum sodium concentration between 130 mmol/L and 150 mmol/L
Exclusion Criteria:
- Age less than 13 years and more than 70 years.
- Traumatic brain injury.
- ICU admission diagnosis of diabetic ketoacidosis, hyperosmolar hyperglycemic state, Child-Pugh class C liver cirrhosis, pregnancy or anticipated survival of less than 24 hours.
- Patients undergoing renal replacement therapy (RRT).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Mechanically ventilated septic patients
|
cumulative sodium balance and cumulative fluid balance will be estimated in the first three days after admission
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
PaO2/FiO2 ratio
Time Frame: first three days after admission
|
first three days after admission
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Length of ICU
Time Frame: first month after admission
|
first month after admission
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU MS76/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sodium Balance
-
Clinical Center of VojvodinaCompletedIntraabdominal Infections | Fluid Balance; Disorder | Sodium Disorder | Chloride DisorderSerbia
-
University of ConnecticutUnited States Department of Defense; AMP Human; Park City, UTCompletedCognitive Change | Electrolyte and Fluid Balance Conditions | Fluid Retention | Heat Exposure | Fluid Loss | Hyperhydration | Sodium RetentionUnited States
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); The George Institute; University...RecruitingDietary Sources of Sodium | Population Sodium IntakeNigeria
-
New York City Department of Health and Mental HygieneCompleted
-
University of Lausanne HospitalsHôpital du Valais; Federal Food Safety and Veterinary OfficeCompleted
-
Tongji HospitalNot yet recruitingHemodynamics Instability | Amobarbital Sodium
-
Johns Hopkins Bloomberg School of Public HealthMcCormick Science InstituteCompletedMaintenance of Recommended Sodium IntakeUnited States
-
Faculdade de Motricidade HumanaCompleted
-
Charite University, Berlin, GermanyCompleted
-
Dong YangXu HongCompletedPolyethylene Glycol | Sodium PhosphateChina
Clinical Trials on Sodium balance
-
Innate srlASST Gaetano Pini-CTORecruiting
-
Biruni UniversityIstanbul UniversityCompleted
-
Riphah International UniversityNot yet recruiting
-
Pôle Saint HélierHopital La MusseCompleted
-
Washington University School of MedicineCompletedCardiovascular DiseasesUnited States
-
University GhentCompletedFunctional Ankle InstabilityBelgium
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Spain, Germany, Belgium, Netherlands, Israel, Italy, Czechia, France, Poland, Switzerland, United Kingdom, South Korea, Russia, Turkey (Türkiye), Ukraine
-
Virginia Polytechnic Institute and State UniversityCompleted
-
Taipei Medical UniversityCompletedExercise | Training | Elderly | Balance | Visual Dependence | MultisensoryTaiwan